Skandinaviska Enskilda Banken (SEB)
ENTA icon

Skandinaviska Enskilda Banken (SEB)’s Enanta Pharmaceuticals ENTA Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,526
Closed -$709K – 956
2023
Q1 		$709K Sell
17,526
-812
-4% -$38.8K 0.01% 730
2022
Q4 		$853K Sell
18,338
-1,062
-5% -$48.4K 0.01% 685
2022
Q3 		$1.01M Hold
19,400
– – 0.01% 679
2022
Q2 		$917K Hold
19,400
– – 0.01% 724
2022
Q1 		$1.38M Buy
19,400
+5,259
+37% +$342K 0.01% 696
2021
Q4 		$1.05M Buy
+14,141
New +$1.11M 0.01% 763
2020
Q3 		– Sell
-9,400
Closed -$472K – 1054
2020
Q2 		$472K Sell
9,400
-21,900
-70% -$1.13M ﹤0.01% 820
2020
Q1 		$1.61M Sell
31,300
-1,900
-6% -$101K 0.02% 528
2019
Q4 		$2.05M Buy
33,200
+4,300
+15% +$267K 0.02% 560
2019
Q3 		$1.74M Buy
28,900
+4,900
+20% +$364K 0.01% 574
2019
Q2 		$2.02M Sell
24,000
-5,900
-20% -$531K 0.02% 510
2019
Q1 		$2.86M Sell
29,900
-4,600
-13% -$413K 0.03% 388
2018
Q4 		$2.44M Buy
+34,500
New +$2.65M 0.02% 422
2016
Q3 		– Sell
-67,900
Closed -$1.5M – 716
2016
Q2 		$1.5M Sell
67,900
-88,500
-57% -$2.32M 0.02% 524
2016
Q1 		$4.59M Sell
156,400
-36,100
-19% -$1.01M 0.05% 257
2015
Q4 		$6.44M Buy
+192,500
New +$6.27M 0.08% 186

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s ENTA Position: Q2 2023 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Enanta Pharmaceuticals (ENTA) in Q2 2023, closing a stake of 17,526 shares — an estimated $709K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ENTA in Q4 2015 and held it in 16 quarters. The position peaked at $6.44M in Q4 2015. 134 funds tracked by Wall St. Rank hold ENTA as of Q2 2023.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Enanta Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 17,526 Enanta Pharmaceuticals shares in Q2 2023, an estimated $709K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Enanta Pharmaceuticals in Q4 2015 and held it in 16 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Enanta Pharmaceuticals position peaked at $6.44M in Q4 2015.
  • 134 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2023.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2023, filed 7 Aug 2023.